PubMed Tkalcevic, V.I., Cuzic, S., Brajsa, K., Mildner, B., Bokulic, A., Situm, K., Perovic, D., Glojnaric, I., Parnham, M.J
This combined approach is often discussed for people who need additional appetite control beyond GLP1 therapy alone
To a considerable degree
Started with 1 mg daily subcutaneous injections while also applying a topical version to my scalp before bed
[8] Early small-scale research suggested it may stimulate lipolysis (the breakdown of fat) and inhibit lipogenesis (fat storage), with preliminary data indicating it may not significantly affect blood glucose or insulin-like growth factor-1 (IGF-1) levels